Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Worse renal transplant outcomes with sirolimus–mycophenolate than with calcineurin inhibitor regimens

Nature Clinical Practice Nephrology volume 3, pages 424–425 (2007)Cite this article

boxed-textSrinivas TR et al. (2007) Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Am J Transplant 7: 586–594

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Groth CG et al. (1999) Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 67: 1036–1042

    Article  CAS  Google Scholar 

  2. Kreis H et al. (2000) Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 69: 1252–1260

    Article  CAS  Google Scholar 

  3. Flechner SM et al. (2002) Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 74: 1070–1076

    Article  CAS  Google Scholar 

  4. Webster AC et al. (2006) Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation 81: 1234–1248

    Article  CAS  Google Scholar 

  5. Larson TS et al. (2006) Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant 6: 514–522

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Hôpital Necker, Service de Transplantation, 161 Rue de Sèvres, Paris Cedex 15, 757343, France kreis@necker.fr

Authors and Affiliations

  1. H Kreis is a Professor of Nephrology and a Consultant in the Transplantation Department at Necker Hospital, Paris, France.,

    Henri Kreis

Authors
  1. Henri Kreis
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kreis, H. Worse renal transplant outcomes with sirolimus–mycophenolate than with calcineurin inhibitor regimens. Nat Rev Nephrol 3, 424–425 (2007). https://doi.org/10.1038/ncpneph0530

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0530

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing